Skip to main content
Hit enter to search or ESC to close
Close Search
Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact
twitter
facebook
linkedin
Investors
Media Coverage
NASDAQ: ENVB
Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Media Coverage
Enveric Biosciences Buys MagicMed In All Inventory Deal Valued At $30 Million [Marijuana Mag]
May 24, 2021
Oncology Peer Review On-The-Go: 1-on-1 with David Johnson: Enveric’s Endocannabinoid Products for Glioblastoma [Cancer Network]
April 13, 2021
Happy Employees = Happy Shareholders [Fortune]
April 13, 2021
Enveric Biosciences CEO Describes How the Group Has ‘Multiple Shots on Goal’ with Current Pipeline [Proactive Investors]
April 7, 2021
David Johnson, Chairman and CEO of Enveric Biosciences [The Green Rush Podcast]
March 25, 2021
Enveric’s Patient-Centric Model to Enhance the Quality of Life of Cancer Patients [Benzinga]
March 24, 2021
Enveric Biosciences on Acquisition of Exclusive License from Diverse Biotech and Value Catalysts [SNN]
March 17, 2021
Enveric Biosciences Acquires License for Diverse Biotech’s Novel Molecules [Pharmaceutical Technology]
March 11, 2021
Enveric Biosciences Signs Licensing Agreement with Diverse Biotech [Pharmaceutical Business Review]
March 11, 2021
CBD-focused Enveric Biosciences Stock Soars on Heavy Volume After License Deal with Cancer Treatment Company [Market Watch]
March 10, 2021
‹
1
…
6
7
8
9
10
›
Close Menu
Company
Team
Psybrary™
Pipeline
Investors
Investor Overview
Press Releases
Media Coverage
Events + Presentations
Stock Information
SEC Filings
Corporate Governance
News Alerts
Contact